App Teaches Doctors to Diagnose Skin Cancer

NCT05661370 | Completed

• 1 other identifier: GP-Learn
• Study Type: interventional
• Target: 3
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to examine if self-paced learning with a novel digital patient-case-based educational platform can increase primary care physicians' diagnostic accuracy of malignant and benign skin lesions on both the level of benign/malignant and the diagnosis level. Secondarily the study aimed to investigate the time spent in reaching this change in proficiency.

Conditions

Melanoma (Skin); Carcinoma

Keywords

Digital Learning; e-learning; Melanoma; Carcinoma; Dermoscopy; Dermloop

Outcome Measures

Primary Outcomes (1)

• Multiple-Choice Questionnaire (MCQ) Score

  Participants are given a test before and after the intervention using a skin cancer MCQ test with 12 digital-patient cases. A higher score means better diagnostic proficiency. The primary outcome is the change of this score.

  Before and immediately after intervention (On average 19 days after enrollment)

Secondary Outcomes (2)

• Diagnostic proficiencies

  During the 8 days of access to the educational mobile application.

• Time spend

  During the 8 days of access to the educational mobile application.

Study Arms (2)

Intervention

ACTIVE COMPARATOR

Access to educational mobile application for 8 days, diagnosing 500 digital patient-cases.

Other: Dermloop Learn

Control

NO INTERVENTION

Control group receiving no intervention, continuing daily practice.

Interventions

Dermloop Learn OTHER

Educational Mobile Application with a library of digital patient-cases and written learning modules the user can access on 36 common skin lesions, both benign and malignant.

Intervention

Eligibility Criteria

• Age: 18 Years - 120 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Primary Care Physician who works in General Practice

Sponsors & Collaborators

• Herlev Hospital: lead

Study Sites (1)

AISC Research Fascility

Copenhagen, Danmark, 2700, Denmark

Location

Related Publications (1)

• Nervil GG, Ternov NK, Vestergaard T, Solvsten H, Chakera AH, Tolsgaard MG, Holmich LR. Improving Skin Cancer Diagnostics Through a Mobile App With a Large Interactive Image Repository: Randomized Controlled Trial. JMIR Dermatol. 2023 Aug 9;6:e48357. doi: 10.2196/48357.

  PMID: 37624707 DERIVED

MeSH Terms

Conditions

Melanoma; Carcinoma

Condition Hierarchy (Ancestors)

Neuroendocrine Tumors; Neuroectodermal Tumors; Neoplasms, Germ Cell and Embryonal; Neoplasms by Histologic Type; Neoplasms; Neoplasms, Nerve Tissue; Nevi and Melanomas; Skin Neoplasms; Neoplasms by Site; Skin Diseases; Skin and Connective Tissue Diseases; Neoplasms, Glandular and Epithelial

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: OTHER
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Medical Doctor

Model Details: Intervention and Controlgroup parallel design using sequential continues block randomization.

Study Record Dates

• First Submitted: December 5, 2022
• First Posted: December 22, 2022
• Study Start: November 15, 2021
• Primary Completion: January 15, 2022
• Study Completion: August 15, 2022
• Last Updated: July 24, 2023

Record last verified: 2023-07

Data Sharing

• IPD Sharing: Will share
• Time Frame: After publication
• Access Criteria: Researchers with interest in skin cancer diagnostics.

Locations

DK (1)